Adverse events (worst grade) that were possibly, probably or definitely related to ipilimumab (N = 35; incidence ≥2)*.
收藏数据链接：
官方服务：
资源简介：
*One patient with a history of gastroesophageal reflux disease and irritable bowel syndrome developed grade 3 nausea, vomiting, gastroparesis and achalasia after one dose of ipilimumab. One case of grade 4 uric acid elevation was considered possibly related to ipilimumab.
创建时间：
2015-12-02
